Mechelen, Belgium

Sébastien Laurent Xavier Martina

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 6.6

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: The Innovations of Sebastien Laurent Xavier Martina

Introduction

Sebastien Laurent Xavier Martina is a notable inventor based in Mechelen, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory disorders. His work is characterized by a focus on developing compounds that address various medical conditions.

Latest Patents

Sebastien holds a patent for "Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders." This invention discloses compounds according to Formula I, which are designed for the prophylaxis and treatment of allergic diseases, inflammatory diseases, metabolic diseases, autoinflammatory diseases, autoimmune diseases, proliferative diseases, transplantation rejection, and other related conditions. The patent emphasizes the methods for producing these compounds and their pharmaceutical compositions.

Career Highlights

Sebastien is currently associated with Galapagos NV, a company known for its innovative approaches in drug discovery and development. His work at Galapagos has allowed him to contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Sebastien has collaborated with notable colleagues, including Steven Emiel Van Der Plas and Oscar Mammoliti. These collaborations have further enhanced the impact of his research and innovations in the field.

Conclusion

Sebastien Laurent Xavier Martina's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical treatments for inflammatory disorders. His patent and work at Galapagos NV highlight the importance of research and collaboration in the pursuit of effective therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…